Key facts
- This page summarizes Jennifer A. Fox's Form 4 filing for Nuvation Bio Inc. (NUVB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Mar 2023, 16:58.
Jennifer A. Fox - 28 Feb 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- NUVB
- Reported as of
- 28 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2023, 16:58:54 UTC
- Prior SEC filing
- 22 Sep 2022
- Next SEC filing
- 13 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- Jennifer A. Fox, by /s/ Ron A. Metzger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jennifer A. Fox filed Form 4 for Nuvation Bio Inc. (NUVB) on 02 Mar 2023.
Change
- Previous filing in this sequence was filed on 22 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUVB
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,481
- Date
- 28 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUVB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +600,000
- Change %
- Price
- $0.000000
- Shares after
- 600,000
- Date
- 28 Feb 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 600,000
- Exercise price
- $1.94
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 2,774 shares acquired on May 19, 2022 and 1 share acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
Footnote F2
Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.